Krupa Pandey, MD
Neurology · Albany, NYNPI 1255501508
Payments from drug & device makers
Across 975 payments — averaging $3855.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech, Inc.$1.8M
- Novartis$818K
- Sanofi$301K
- E.r. Squibb & Sons, L.L.C.$287K
- Biogen$167K
- Bristol Myers Squibb$125K
- plus $275K from 21 others
Across 8 payments — averaging $1710.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$13K
- Sanofi$660
What the payments were for
- Consulting fees$85,43220%
- Speaking & faculty fees$318,88374%
- Travel & lodging$13,4933%
- Food & beverage$15,2394%
- Education$3880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech, Inc. | 117 | $1,786,923 |
| Novartis | 113 | $817,849 |
| Sanofi | 79 | $300,633 |
| E.r. Squibb & Sons, L.L.C. | 35 | $286,751 |
| Biogen | 108 | $167,290 |
| Bristol Myers Squibb | 92 | $124,715 |
| Amgen(2 entities) | 104 | $72,423 |
| Genentech USA, Inc. | 85 | $68,018 |
| EMD Serono, Inc. | 91 | $60,918 |
| Roche Products Limited | 42 | $44,460 |
| AstraZeneca | 37 | $23,689 |
| TG Therapeutics, Inc. | 5 | $3,946 |
| Teva Pharmaceuticals USA, Inc. | 14 | $222 |
| Johnson & Johnson | 19 | $217 |
| AbbVie(2 entities) | 11 | $168 |
| Lilly USA, LLC | 11 | $164 |
| SK Life Science, Inc. | 1 | $147 |
| Biohaven Pharmaceuticals, Inc. | 1 | $75 |
| Lundbeck LLC | 2 | $31 |
| F. Hoffmann-la Roche AG | 1 | $22 |
| Philips North America LLC | 1 | $21 |
| Neurocrine Biosciences, Inc. | 1 | $17 |
| Mallinckrodt Enterprises LLC | 1 | $16 |
| Merz Pharmaceuticals, LLC | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $15 |
| Avanir Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,758,776 in reported general payments places this provider in the 95th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 48 | $452,777 |
| AmpyraDalfampridine | 12 | $57,617 |
| Glatiramer Acetate | 15 | $30,975 |
| Dalfampridine ErDalfampridine | 39 | $13,449 |
| Baclofen | 64 | $1,843 |
| Teriflunomide | 14 | $626 |
| Gabapentin | 17 | $361 |
| Amitriptyline Hcl | 12 | $210 |
Paid to pharmacies, not to this prescriber.
Other neurology in Albany
- Richard HolubAlbany$6.3M
- Charles ArgoffAlbany$1.7M
- David HartAlbany$1.7M
- Christian GrommesNew York$9.9M
- Ilya KisterNew York$9.5M
- E DorseyNew York$8.5M
- Lauren SchaffNew York$8.2M
- Martin SadowskiNew York$5.4M
- Lawrence HonigNew York$4.9M
- Laszlo MechtlerAmherst$4.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.